Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Explore Our Diverse Range Of Offerings
From detailed reports to experts services offered in 15+
Industry Domains
Add 2 More Reports For 20% off
Report Overview
The vaccine market was valued at USD 75.22 Billion in 2025. It is poised to grow at a CAGR of 10.50% during the forecast period of 2026-2035, and reach USD 204.15 Billion by 2035. The market growth is driven by rising infectious disease burden, expanding immunization programs, increasing government initiatives, growing awareness of preventive healthcare, and continuous advancements in vaccine technologies globally.
Key Market Trends and Insights
- By route of administration, the parenteral segment is expected to lead the market with a share of over 84% in the historical period.
- By age group, the adult vaccines segment is expected to lead the market with a share of above 56% in the historical period.
- North America is expected to dominate the global market with a share of about 39% in the historical period.
Market Size and Forecast
- Market Size (2025): USD 75.22 Billion
- Projected Market Size (2035): USD 204.15 Billion
- CAGR (2026-2035): 10.50%
2025
Base Year
2019-2025
Historical Period
2026-2035
Forecast Period
-
In February 2026, WHO emphasized strengthened global immunization strategies and expanded vaccination programs to reduce the infectious disease burden and improve worldwide preventive healthcare systems.
-
In April 2026, Moderna initiated Phase III trials of its mRNA bird flu vaccine across the US and UK, targeting emerging pandemic influenza strains.
-
In August 2025, Pfizer and BioNTech received US FDA approval for the updated COMIRNATY COVID-19 vaccine formulation targeting current circulating variants for the 2025-2026 season.
Compound Annual Growth Rate
10.5%
Value in USD Billion
2026-2035
*this image is indicative*
Vaccine Market Overview
The market is driven by rising infectious disease prevalence, expanding immunization programs, and increasing awareness of preventive healthcare. Government initiatives and global vaccination campaigns support sustained demand. Technological advancements, including mRNA and recombinant platforms, are enhancing vaccine efficacy and production efficiency. Strong investments and partnerships continue to expand access, supporting consistent growth across developed and emerging healthcare markets worldwide. The market reached a value of approximately USD 75.22 Billion in 2025.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Vaccine Market Growth Drivers
Advanced mRNA Vaccine Development Driving the Market Demand
Increasing pandemic preparedness requirements and rising investment in next-generation vaccine technologies are key growth drivers. For instance, in April 2026, Moderna initiated a late-stage Phase III trial for its mRNA-based bird flu vaccine across the US and UK to evaluate efficacy against emerging strains. This advancement is expected to strengthen pandemic preparedness by accelerating innovative vaccine development and global response capabilities in the forecast period.
Vaccine Market Trends
Key trends shaping the market include increasing immunization coverage, advancements in vaccine technologies, expanding public-private partnerships, and rising focus on pandemic preparedness globally.
Global Vaccine Policy Strengthening the Market Expansion
Rising infectious disease burden and increasing government immunization initiatives are key market drivers. For instance, in February 2026, the World Health Organization emphasized expanded vaccination strategies and global immunization strengthening to reduce the impact worldwide. This development is expected to enhance the vaccination coverage by improving preventive healthcare systems and accelerating coordinated global immunization adoption in the forecast period.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Vaccine Market Segmentation
Market Breakup by Vaccine Type
- Conjugate Vaccines
- Inactivated Vaccines
- Live Attenuated Vaccines
- mRNA Vaccines
- Recombinant Vaccines
- Toxoid Vaccines
- Viral-Vector Vaccines
- Others
Market Breakup by Type
- Monovalent Vaccines
- Multivalent Vaccines
Market Breakup by Indication
- DTP
- Hepatitis
- Herpes Zoster
- HPV
- Influenza
- Meningococcal Disease
- MMR
- Pneumococcal Disease
- Polio
- Rotavirus
- RSV
- Others
Market Breakup by Route of Administration
- Oral
- Parenteral
- Others
Market Breakup by Age Group
- Adult Vaccines
- Pediatric Vaccines
- Others
Market Breakup by Distribution Channel
- Hospitals and Clinics
- Retail pharmacies
- Online Channels
- Government Suppliers
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Vaccine Market Share
Parenteral Likely to Dominate the Market Segment by Route of Administration
The parenteral segment likely accounted for approximately 84% of the market share in the historical period, supported by its widespread use in routine immunization programs and established efficacy. Strong healthcare infrastructure and clinical preference are further expected to reinforce its position. The segment is likely to dominate due to consistent demand patterns and reliable delivery mechanisms, strengthening overall vaccination uptake across global healthcare systems and preventive strategies.
Purchase the Regional Overview for USD 1099
If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.
Purchase the Regional Overview for USD 1099
If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.
Purchase the Regional Overview for USD 1099
If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.
Purchase the Regional Overview for USD 1099
If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.
Vaccine Market Analysis by Region
North America is expected to account for over 39% of the global share in the histrical period, supported by advanced healthcare infrastructure and strong immunization frameworks. High awareness levels and continuous investment in vaccine development sustain regional growth. The region is likely to dominate due to widespread adoption and government-backed programs, enhancing overall healthcare infrastructure across diverse population groups and improving vaccination accessibility.
Leading Players in the Vaccine Market
The key features of the market report comprise patent analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
AstraZeneca plc
Founded in 1999 and headquartered in Cambridge, United Kingdom, AstraZeneca plc is a global biopharmaceutical company. Its vaccine portfolio includes COVID-19 and respiratory immunization solutions developed through strategic collaborations. The company emphasizes innovation and large-scale manufacturing, supporting global immunization efforts and strengthening overall biopharmaceutical innovation across preventive healthcare systems worldwide.
Bavarian Nordic A/S
Established in 1994 and headquartered in Hellerup, Denmark, Bavarian Nordic A/S specializes in vaccine development for infectious diseases. Its portfolio includes vaccines for smallpox, mpox, and rabies. The company focuses on advanced immunization technologies and global supply expansion, enhancing vaccine developmentthrough strategic partnerships and government-supported programs globally.
Bharat Biotech Int’l Ltd
Founded in 1996 and headquartered in Hyderabad, India, Bharat Biotech Int’l Ltd is a leading vaccine manufacturer. Its portfolio includes vaccines for COVID-19, rotavirus, and cholera. The company emphasizes affordable innovation and global accessibility, strengthening immunization programs through scalable production and expanding presence in emerging and developed markets worldwide.
Biological E Ltd
Established in 1953 and headquartered in Hyderabad, India, Biological E Ltd is a prominent vaccine producer. Its portfolio includes pediatric vaccines and COVID-19 immunization solutions. The company focuses on expanding manufacturing capabilities and global distribution, supporting public health initiatives through partnerships with international organizations and government immunization programs globally.
Other key players in the market are CSL Seqirus, Daiichi Sankyo Co. Ltd, Merck & Co., Inc, Emergent BioSolutions, GlaxoSmithKline plc, and Johnson & Johnson.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Key Questions Answered in the Vaccine Market Report
- What was the vaccine market value in 2025?
- What is the vaccine market forecast outlook for 2026-2035?
- What major factors aid the demand for vaccine market?
- How has the market performed so far, and how is it anticipated to perform in the coming years?
- What are the market’s major drivers, opportunities, and restraints?
- What are the major vaccine market trends?
- Which vaccine type is expected to dominate the market segment?
- Which type is likely to dominate the market segment?
- Which indication is anticipated to dominate the market segment?
- Which route of administration is expected to dominate the market segment?
- Which age group is likely to dominate the market segment?
- Which distribution channel is anticipated to dominate the market segment?
- Who are the key players in the vaccine market?
- What are the current unmet needs and challenges in the market?
- How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?
Pricing Plans
Upto 15% Off
USD
-
$3299 $2969
-
$5499 $4949
-
$6999 $5949
-
$8199 $6969
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Looking for specific insights?
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Report Summary
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Vaccine Type |
|
| Breakup by Type |
|
| Breakup by Indication |
|
| Breakup by Route of Administration |
|
| Breakup by Age Group |
|
| Breakup by Distribution Channel |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
- Selected Segments
- Printing Restrictions
- Excel Spreadsheet Delivered via Email
- Full Report
- Periodic Updates
- Post Sales Analysts Support
- Unlimited Prints
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
- All Segments
- Printing Restrictions
- PDF Delivered via Email
- Custom Report Layout
- Post Sales Analysts Support
- Periodic Updates
- Unlimited Prints
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
- All Segments
- Five Prints Available
- PDF Delivered via Email
- Limited Free Customization
- Post Sales Analyst Support
- Custom Report Layout
- Periodic Updates
- Unlimited Prints
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
- All Segments
- Unlimited Prints Available
- PDF & Excel Delivery via Email
- Limited Free Customization
- Post Sales Analysts Support
- Discount On Next Update
- Custom Report Layout
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Bundle Type
Flash Bundle
20% OFF
Number of Reports: 3
Small Business Bundle
25% OFF
Number of Reports: 5
Growth Bundle
30% OFF
Number of Reports: 8
Enterprise Bundle
35% OFF
Number of Reports: 10
Overview
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 80 Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 100 Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
- 3 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- Complimentary Excel Data Set
- PPT Version of the Report
- Power BI Dashboards
- License Upgrade
- Free Analyst Hours
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
- 5 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- Complimentary Excel Data Set
- PPT Version of the Report
- Power BI Dashboards
- License Upgrade
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
- 8 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- License Upgrade
- Free Analyst Hours - 80 Hours
- Power BI Dashboards
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
- 10 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- License Upgrade
- Power BI Dashboards
- Free Analyst Hours - 100 Hours
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share